| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.0009 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |